Leukotriene receptor antagonist and H1-receptor antagonist combination

This page covers all Leukotriene receptor antagonist and H1-receptor antagonist combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CysLT1 receptor (montelukast); H1 histamine receptor (cetirizine).

Targets

CysLT1 receptor (montelukast); H1 histamine receptor (cetirizine)

Marketed (1)

• montelukast and cetirizine · Medical University of Lodz · Immunology / Allergy
  This combination blocks leukotriene receptors (montelukast) and histamine H1 receptors (cetirizine) to reduce allergic inflammation and symptoms.

Patent intelligence

• leukotriene receptor antagonist and h1 receptor antagonist combination patent landscape — aggregated cliff calendar, attackable patents, originator estates